Elevated BAFF levels have been associated with the production of autoAbs in autoimmune diseases such as SLE, leading to the development of anti-BAFF biologics such as Belimumab which works by depleting the IgG autoAbs (39). This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.